title: Effects of peroxisome proliferators and/or hypothyroidism on xenobiotic-metabolizing enzymes in rat testis.
abstract: The objectives of the present work were to study the effects of certain peroxisome proliferators on xenobiotic-metabolizing enzyme activities in the testes of normal and hypothyroid rats, i.e. phenol sulfotransferases (pST), phenol UDP-glucuronosyl transferases (pUDPGT), glutathione transferases (GST), catalase, epoxide hydrolase (EH), glutathione peroxidase (GPX) and NAD(P)H quinone oxidoreductase (QR). Adult male rats (normal and hypothyroid) were treated for 10 days with clofibrate (0.5%), perfluorooctanoic acid (0.5%, PFOA), acetylsalisylic acid (1%, ASA) and di(2-ethylhexyl)phthalate (2%, DEHP) in their diet. The results show that treatment of normal rats with peroxisome proliferators dramatically affects the activities of xenobiotic-metabolizing enzymes (40-60% reduction). The highest effects are seen in catalase activity (50-60% with PFOA and ASA), pUDPGT (55% with PFOA), pST (55% with PFOA) and QR (50% with DEHP). These effects are not seen or are weaker after induction of hypothyroidism. Taken together, it is concluded that different classes of peroxisome proliferators have different effects on rat testicular xenobiotic-metabolizing enzymes.
authors.affiliation: Department of Biochemistry, Wallenberg Laboratory, Stockholm University, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Mehrotra
authors.forename: R
authors.initials: R
authors.lastname: Morgenstern
authors.forename: G
authors.initials: G
authors.lastname: Lundqvist
authors.forename: L
authors.initials: L
authors.lastname: Becedas
authors.forename: M
authors.initials: M
authors.lastname: Bengtsson Ahlberg
authors.forename: A
authors.initials: A
authors.lastname: Georgellis
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000633:toxicity; D015239:Arylsulfotransferase / Q000378:metabolism; D001241:Aspirin / Q000008:administration & dosage / Q000633:toxicity; D002210:Caprylates / Q000008:administration & dosage / Q000633:toxicity; D002374:Catalase / Q000378:metabolism; D002994:Clofibrate / Q000008:administration & dosage / Q000633:toxicity; D004032:Diet; D004051:Diethylhexyl Phthalate / Q000008:administration & dosage / Q000633:toxicity; D004195:Disease Models, Animal; D004851:Epoxide Hydrolases / Q000378:metabolism; D005466:Fluorocarbons / Q000008:administration & dosage / Q000633:toxicity; D014453:Glucuronosyltransferase / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism; D005982:Glutathione Transferase / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000633:toxicity; D007037:Hypothyroidism / Q000503:physiopathology*; D008297:Male; D008830:Microbodies / Q000187:drug effects* / Q000201:enzymology; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013737:Testis / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002210:Caprylates; D005466:Fluorocarbons; D000960:Hypolipidemic Agents; C023036:perfluorooctanoic acid; D004051:Diethylhexyl Phthalate; D002374:Catalase; D005979:Glutathione Peroxidase; D016660:NAD(P)H Dehydrogenase (Quinone); D014453:Glucuronosyltransferase; D005982:Glutathione Transferase; D015239:Arylsulfotransferase; D004851:Epoxide Hydrolases; D002994:Clofibrate; D001241:Aspirin